The company successfully developed/mass-manufactured a non-toxic, highly effective nanomedicine, ONX-1006.Such a unique, innovative, and precise nano-delivery technology platform results in the apoptosis of tumor cells only. It ultimately reduces treatment-emergent adverse events while achieving groundbreaking efficacy. Thus, it will reduce the pancreatic cancer death rate by more than 70% with very minimum or no side effects.